Administer’s Q2 EBITDA soared by 320% y/y, reaching EUR 1.
Exel’s Q2 was encouraging as EBIT recovered significantly after a challenging period of missing dema...
We expect flat sales for H2 with a decrease in domestic net sales due to non-recurring wholesale del...
Endomines' net sales for the first half of the year were roughly as expected, though profitability d...
Administer’s Q2 net sales declined by 1.3% y/y, mainly attributable to the demand for personnel leas...
Dovre’s Q2 results were a bit higher than we estimated as Project Personnel and Consulting came in s...
Aspo’s Q2 earnings were basically in line with estimates.
Redeye comments on Nitro Games' Q2 2024 report, which came in better than expected, both in sales an...
Q2: Revenues 5% above, EBIT of DKK 41m vs. ABGSCe 30m Cutting EBIT guidance on new investments in SD...
CirChem (”CirChem” eller ”Bolaget”) har publicerat Bolagets delårsrapport för det andra kvartalet 20...
Redeye is positive to Bredband2’s acquisition of Bredbandsson, adding about 0.
Group net sales was EUR 31.7m in Q2 (Nordea est. EUR 30.
Redeye provides a research update following the Q2 2024 report from Precise Biometrics.
Redeye states that BeammWave’s Q2 report aligned with expectations.
Björn Borg (”Björn Borg” or ”the Company”) published its Q2 report for 2024 on the 16th of August, 2...
Investment management to be main earnings contributor in Q2 Continued weak market activity makes us ...
Redeye remains confident on the case as Railcare showed surprisingly strong sales growth of 24% in Q...
Redeye states BeammWave's Q2 report aligned with expectations.
Redeye gives its initial comments on the Q2 2024 report from Precise Biometrics.
11% adj. EBITA miss but improvement already in Q3 '24e adj.
